Literature DB >> 212577

Effects of adenine arabinoside on lymphocytes infected with Epstein-Barr virus.

W C Benz, P J Siegel, J Baer.   

Abstract

Low concentrations of adenine arabinoside inhibited growth of two Epstein-Barr virus producer cell lines in culture, while not significantly affecting a nonproducer cell line and a B-cell-negative line. These observations were extended to include freshly infected cells. Mitogen-stimulated human umbilical cord blood lymphocytes were unaffected by the drug at concentration levels that inhibited [3H]thymidine incorporation into the DNA of Epstein-Barr virus-stimulated cells. DNA synthesis in Epstein-Barr virus-superinfected Raji cells was also adversely affected by adenine arabinoside. However, these same low concentrations of adenine arabinoside in the triphosphate form produced less effect on DNA synthesis in nuclear systems and DNA polymerase assays than on growth or DNA synthesis in whole cells. Therefore the effects reported here of low concentrations of the drug on whole cells may be only in part related to DNA polymerase inhibition. The work reported here suggests that adenine arabinoside has multiple sites of action in infected cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212577      PMCID: PMC525834     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  IN VITRO CHROMOSOME BREAKAGE INDUCED BY ARABINOSYLADENINE IN HUMAN LEUKOCYTES.

Authors:  W W NICHOLS
Journal:  Cancer Res       Date:  1964-09       Impact factor: 12.701

2.  [EFFECT OF 2 ARABINOSE NUCLEOSIDES ON THE MULTIPLICATION OF HERPES VIRUS AND VACCINE IN CELL CULTURE].

Authors:  M PRIVATDEGARILHE; J DE RUDDER
Journal:  C R Hebd Seances Acad Sci       Date:  1964-10-19

3.  CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA).

Authors:  J V PULVERTAFT
Journal:  Lancet       Date:  1964-02-01       Impact factor: 79.321

4.  9-BETA-D-ARABINOFURANOSYLADENINE AS AN INHIBITOR OF METABOLISM IN NORMAL AND NEOPLASTIC CELLS.

Authors:  J J BRINK; G A LEPAGE
Journal:  Can J Biochem       Date:  1965-01

5.  Epstein-Barr virus DNA synthesized in superinfected Raji cells.

Authors:  J E Shaw; T Seebeck; J L Li; J S Pagano
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

6.  Effect of 9-beta-D-arabinofuranosyladenine on DNA synthesis in vivo.

Authors:  W E Müller; A Maidhof; R K Zahn; W M Shannon
Journal:  Cancer Res       Date:  1977-07       Impact factor: 12.701

7.  Inhibition of herpesvirus DNA synthesis by 9-beta-D-arabinofuranosyladenine in cellular and cell-free systems.

Authors:  W E Müller; R K Zahn; K Bittlingmaier; D Falke
Journal:  Ann N Y Acad Sci       Date:  1977-03-04       Impact factor: 5.691

8.  Determination of plaque inhibitory activity of adenine arabinoside (9-beta-D-arabinofuranosyladenine) for herpesviruses using an adenosine deaminase inhibitor.

Authors:  Y Bryson; J D Connor; L Sweetman; S Carey; M A Stuckey; R Buchanan
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

9.  Effect of adenine arabinoside on Epstein-Barr virus in vitro.

Authors:  M Coker-Vann; R Dolin
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

10.  Inhibition of mammalian DNA polymerase by the 5'-triphosphate of 1-beta-d-arabinofuranosylcytosine and the 5'-triphosphate of 9-beta-d-arabinofuranoxyladenine.

Authors:  J J Furth; S S Cohen
Journal:  Cancer Res       Date:  1968-10       Impact factor: 12.701

View more
  6 in total

1.  Immunofluorescence microscopy and flow cytometry characterization of chemical induction of latent Epstein-Barr virus.

Authors:  H B Jenson; G M Grant; Y Ench; P Heard; C A Thomas; S G Hilsenbeck; M P Moyer
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

2.  Effects of nucleoside analogs on Epstein-Barr virus-induced transformation of human umbilical cord leukocytes and Epstein-Barr virus expression in transformed cells.

Authors:  E E Henderson; W K Long; R Ribecky
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

3.  Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon.

Authors:  P W Doetsch; R J Suhadolnik; Y Sawada; J D Mosca; M B Flick; N L Reichenbach; A Q Dang; J M Wu; R Charubala; W Pfleiderer; E E Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

4.  Sedimentation characteristics of newly synthesized Epstein-Barr viral DNA in superinfected cells.

Authors:  P J Siegel; W Clough; J L Strominger
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

5.  Rescue of IgM, IgG, and IgA production in common varied immunodeficiency by T cell-independent stimulation with Epstein-Barr virus.

Authors:  G Jeong; P Ralph; I Nakoinz; O Saiki; C Cunningham-Rundles
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

6.  Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole.

Authors:  V L Zacny; E Gershburg; M G Davis; K K Biron; J S Pagano
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.